• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 WNT 信号转导调控,纠正成年发病亨廷顿病 iPSC 衍生神经元培养中的异常发育。

Aberrant Development Corrected in Adult-Onset Huntington's Disease iPSC-Derived Neuronal Cultures via WNT Signaling Modulation.

机构信息

Department of Psychiatry and Human Behavior, University of California Irvine, Irvine, CA 92697, USA.

Department of Neurobiology and Behavior, University of California Irvine, Irvine, CA 96267, USA.

出版信息

Stem Cell Reports. 2020 Mar 10;14(3):406-419. doi: 10.1016/j.stemcr.2020.01.015. Epub 2020 Feb 27.

DOI:10.1016/j.stemcr.2020.01.015
PMID:32109367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7066322/
Abstract

Aberrant neuronal development and the persistence of mitotic cellular populations have been implicated in a multitude of neurological disorders, including Huntington's disease (HD). However, the mechanism underlying this potential pathology remains unclear. We used a modified protocol to differentiate induced pluripotent stem cells (iPSCs) from HD patients and unaffected controls into neuronal cultures enriched for medium spiny neurons, the cell type most affected in HD. We performed single-cell and bulk transcriptomic and epigenomic analyses and demonstrated that a persistent cyclin D1 neural stem cell (NSC) population is observed selectively in adult-onset HD iPSCs during differentiation. Treatment with a WNT inhibitor abrogates this NSC population while preserving neurons. Taken together, our findings identify a mechanism that may promote aberrant neurodevelopment and adult neurogenesis in adult-onset HD striatal neurons with the potential for therapeutic compensation.

摘要

异常的神经元发育和有丝分裂细胞群体的持续存在与多种神经疾病有关,包括亨廷顿病(HD)。然而,这种潜在病理学的机制尚不清楚。我们使用改良的方案将来自 HD 患者和未受影响的对照者的诱导多能干细胞(iPSC)分化为富含中型棘突神经元的神经元培养物,这是 HD 中受影响最大的细胞类型。我们进行了单细胞和批量转录组和表观基因组分析,结果表明,在分化过程中,选择性地在成年发病的 HD iPSC 中观察到持续存在的细胞周期蛋白 D1 神经干细胞(NSC)群体。用 WNT 抑制剂处理可消除该 NSC 群体,同时保留神经元。总之,我们的研究结果确定了一种可能促进成年发病的 HD 纹状体神经元异常神经发育和成年神经发生的机制,具有潜在的治疗补偿作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310d/7066322/765660a70a96/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310d/7066322/da4665c3e2d4/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310d/7066322/5d124eaf7020/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310d/7066322/9e7432248e39/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310d/7066322/7ebce05f196d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310d/7066322/6131b2db48d2/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310d/7066322/53a806b51960/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310d/7066322/765660a70a96/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310d/7066322/da4665c3e2d4/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310d/7066322/5d124eaf7020/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310d/7066322/9e7432248e39/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310d/7066322/7ebce05f196d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310d/7066322/6131b2db48d2/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310d/7066322/53a806b51960/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310d/7066322/765660a70a96/gr6.jpg

相似文献

1
Aberrant Development Corrected in Adult-Onset Huntington's Disease iPSC-Derived Neuronal Cultures via WNT Signaling Modulation.通过 WNT 信号转导调控,纠正成年发病亨廷顿病 iPSC 衍生神经元培养中的异常发育。
Stem Cell Reports. 2020 Mar 10;14(3):406-419. doi: 10.1016/j.stemcr.2020.01.015. Epub 2020 Feb 27.
2
Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.由患者诱导多能干细胞产生的星形胶质细胞再现亨廷顿病患者细胞的特征。
Mol Brain. 2012 May 21;5:17. doi: 10.1186/1756-6606-5-17.
3
FOXOs modulate proteasome activity in human-induced pluripotent stem cells of Huntington's disease and their derived neural cells.FOXO蛋白在亨廷顿舞蹈病的人类诱导多能干细胞及其衍生神经细胞中调节蛋白酶体活性。
Hum Mol Genet. 2017 Nov 15;26(22):4416-4428. doi: 10.1093/hmg/ddx327.
4
Human Huntington's Disease iPSC-Derived Cortical Neurons Display Altered Transcriptomics, Morphology, and Maturation.人源亨廷顿舞蹈病 iPSC 衍生皮质神经元表现出转录组、形态和成熟改变。
Cell Rep. 2018 Oct 23;25(4):1081-1096.e6. doi: 10.1016/j.celrep.2018.09.076.
5
Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells.亨廷顿病患者来源诱导多能干细胞的神经元特性、体内作用及病理学。
Stem Cells. 2012 Sep;30(9):2054-62. doi: 10.1002/stem.1135.
6
Genomic Analysis Reveals Disruption of Striatal Neuronal Development and Therapeutic Targets in Human Huntington's Disease Neural Stem Cells.基因组分析揭示了人类亨廷顿病神经干细胞纹状体神经元发育的破坏和治疗靶点。
Stem Cell Reports. 2015 Dec 8;5(6):1023-1038. doi: 10.1016/j.stemcr.2015.11.005.
7
Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.亨廷顿病猴诱导多能干细胞源性神经祖细胞衍生的星形胶质细胞改善亨廷顿病表型。
PLoS One. 2019 Mar 21;14(3):e0214156. doi: 10.1371/journal.pone.0214156. eCollection 2019.
8
Huntington's Disease iPSC-Derived Brain Microvascular Endothelial Cells Reveal WNT-Mediated Angiogenic and Blood-Brain Barrier Deficits.亨廷顿舞蹈病诱导多能干细胞衍生的脑微血管内皮细胞揭示了WNT介导的血管生成和血脑屏障缺陷。
Cell Rep. 2017 May 16;19(7):1365-1377. doi: 10.1016/j.celrep.2017.04.021.
9
Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells.诱导多能干细胞中亨廷顿病表型的基因矫正。
Cell Stem Cell. 2012 Aug 3;11(2):253-63. doi: 10.1016/j.stem.2012.04.026. Epub 2012 Jun 28.
10
Modeling Huntington's disease with induced pluripotent stem cells.利用诱导多能干细胞建立亨廷顿病模型。
Mol Cell Neurosci. 2013 Sep;56:50-64. doi: 10.1016/j.mcn.2013.02.005. Epub 2013 Feb 28.

引用本文的文献

1
Huntingtin preserves mitochondrial genome integrity in neurons, which is impaired in Huntington's disease.亨廷顿蛋白可维持神经元中线粒体基因组的完整性,而在亨廷顿舞蹈症中这种完整性会受到损害。
bioRxiv. 2025 Jul 24:2025.07.24.666629. doi: 10.1101/2025.07.24.666629.
2
Excess Wnt in neurological disease.神经系统疾病中Wnt信号过度激活
Biochem J. 2025 May 16;482(10):601-18. doi: 10.1042/BCJ20240265.
3
Cerulenin partially corrects the disrupted developmental transcriptomic signature in Huntington's disease striatal medium spiny neurons.浅蓝菌素可部分纠正亨廷顿舞蹈病纹状体中等棘状神经元中紊乱的发育转录组特征。

本文引用的文献

1
The caudate nucleus undergoes dramatic and unique transcriptional changes in human prodromal Huntington's disease brain.尾状核在人类亨廷顿病前驱期大脑中经历显著且独特的转录变化。
BMC Med Genomics. 2019 Oct 16;12(1):137. doi: 10.1186/s12920-019-0581-9.
2
Characterization of Neurodevelopmental Abnormalities in iPSC-Derived Striatal Cultures from Patients with Huntington's Disease.亨廷顿舞蹈病患者诱导多能干细胞衍生的纹状体培养物中神经发育异常的特征分析
J Huntingtons Dis. 2019;8(3):257-269. doi: 10.3233/JHD-180333.
3
Clinical Presentation and Features of Juvenile-Onset Huntington's Disease: A Systematic Review.
Stem Cells. 2025 Jul 21;43(8). doi: 10.1093/stmcls/sxaf029.
4
Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances.生物学与疾病中的Wnt信号通路:机制与治疗进展
Signal Transduct Target Ther. 2025 Apr 4;10(1):106. doi: 10.1038/s41392-025-02142-w.
5
Polyphenols as Wnt/β-catenin pathway modulators: A promising strategy in clinical neurodegeneration.多酚作为Wnt/β-连环蛋白通路调节剂:临床神经退行性变中的一种有前景的策略。
Animal Model Exp Med. 2025 Feb;8(2):266-286. doi: 10.1002/ame2.12525. Epub 2025 Jan 14.
6
Aberrant splicing in Huntington's disease accompanies disrupted TDP-43 activity and altered m6A RNA modification.亨廷顿病中的异常剪接伴随着TDP-43活性的破坏和m6A RNA修饰的改变。
Nat Neurosci. 2025 Feb;28(2):280-292. doi: 10.1038/s41593-024-01850-w. Epub 2025 Jan 6.
7
Leveraging explainable deep learning methodologies to elucidate the biological underpinnings of Huntington's disease using single-cell RNA sequencing data.利用可解释的深度学习方法,利用单细胞 RNA 测序数据阐明亨廷顿病的生物学基础。
BMC Genomics. 2024 Oct 4;25(1):930. doi: 10.1186/s12864-024-10855-5.
8
Poly ADP-ribose signaling is dysregulated in Huntington disease.多聚 ADP - 核糖信号传导在亨廷顿病中失调。
Proc Natl Acad Sci U S A. 2024 Oct;121(40):e2318098121. doi: 10.1073/pnas.2318098121. Epub 2024 Sep 27.
9
The Brain-Gut-Bone Axis in Neurodegenerative Diseases: Insights, Challenges, and Future Prospects.神经退行性疾病中的脑-肠-骨轴:见解、挑战与未来展望。
Adv Sci (Weinh). 2024 Oct;11(38):e2307971. doi: 10.1002/advs.202307971. Epub 2024 Aug 9.
10
ZNF91 is an endogenous repressor of the molecular phenotype associated with X-linked dystonia-parkinsonism (XDP).ZNF91 是与 X 连锁肌张力障碍-帕金森病(XDP)相关分子表型的内源性抑制物。
Proc Natl Acad Sci U S A. 2024 Aug 13;121(33):e2401217121. doi: 10.1073/pnas.2401217121. Epub 2024 Aug 5.
青少年型亨廷顿舞蹈病的临床表现与特征:一项系统综述
J Huntingtons Dis. 2019;8(2):171-179. doi: 10.3233/JHD-180339.
4
Huntingtin Lowering Strategies for Disease Modification in Huntington's Disease.降低亨廷顿病患者亨廷顿蛋白水平的策略。
Neuron. 2019 Mar 6;101(5):801-819. doi: 10.1016/j.neuron.2019.01.039.
5
Unbiased Profiling of Isogenic Huntington Disease hPSC-Derived CNS and Peripheral Cells Reveals Strong Cell-Type Specificity of CAG Length Effects.同源亨廷顿病 hPSC 衍生 CNS 和外周细胞的无偏分析揭示了 CAG 长度效应的强烈细胞类型特异性。
Cell Rep. 2019 Feb 26;26(9):2494-2508.e7. doi: 10.1016/j.celrep.2019.02.008.
6
Chromosomal instability during neurogenesis in Huntington's disease.亨廷顿舞蹈病神经发生过程中的染色体不稳定性
Development. 2018 Jan 29;145(2):dev156844. doi: 10.1242/dev.156844.
7
Faulty neuronal determination and cell polarization are reverted by modulating HD early phenotypes.通过调节 HD 的早期表型可以逆转错误的神经元决定和细胞极化。
Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):E762-E771. doi: 10.1073/pnas.1715865115. Epub 2018 Jan 8.
8
Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges.利用患者来源的诱导多能干细胞建立神经退行性疾病模型:可能性与挑战。
N Biotechnol. 2017 Oct 25;39(Pt B):190-198. doi: 10.1016/j.nbt.2017.05.009. Epub 2017 Jun 2.
9
Huntington's Disease iPSC-Derived Brain Microvascular Endothelial Cells Reveal WNT-Mediated Angiogenic and Blood-Brain Barrier Deficits.亨廷顿舞蹈病诱导多能干细胞衍生的脑微血管内皮细胞揭示了WNT介导的血管生成和血脑屏障缺陷。
Cell Rep. 2017 May 16;19(7):1365-1377. doi: 10.1016/j.celrep.2017.04.021.
10
Huntington Disease as a Neurodevelopmental Disorder and Early Signs of the Disease in Stem Cells.亨廷顿病作为一种神经发育障碍及干细胞中的疾病早期迹象。
Mol Neurobiol. 2018 Apr;55(4):3351-3371. doi: 10.1007/s12035-017-0477-7. Epub 2017 May 11.